Diisopropylethylamine → 2-(4-fluorophenyl)-N-[5-(2-furyl)-1,3,4-oxadiazol-2-yl]-4-quinolinecarboxamide

HRID 1259850

반응식

HRID 1259850 반응식
[NH2:1][C:2]1[O:3][C:4]([C:7]2[O:8][CH:9]=[CH:10][CH:11]=2)=[N:5][N:6]=1.C1C=NC2N(O)N=NC=2C=1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.C(N(CC)C(C)C)(C)C.[F:55][C:56]1[CH:61]=[CH:60][C:59]([C:62]2[CH:71]=[C:70]([C:72](O)=[O:73])[C:69]3[C:64](=[CH:65][CH:66]=[CH:67][CH:68]=3)[N:63]=2)=[CH:58][CH:57]=1>O.CN(C=O)C>[F:55][C:56]1[CH:57]=[CH:58][C:59]([C:62]2[CH:71]=[C:70]([C:72]([NH:1][C:2]3[O:3][C:4]([C:7]4[O:8][CH:9]=[CH:10][CH:11]=4)=[N:5][N:6]=3)=[O:73])[C:69]3[C:64](=[CH:65][CH:66]=[CH:67][CH:68]=3)[N:63]=2)=[CH:60][CH:61]=1

참가 물질

8

반응물 5

HCID 81531DiisopropylethylamineHCID 181649HOAtHCID 2021855-(Furan-2-yl)-1,3,4-oxadiazol-2-amineHCID 7231632-(4-Fluorophenyl)quinoline-4-carboxylic acidHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)

생성물 1

HCID 672041572-(4-fluorophenyl)-N-[5-(2-furyl)-1,3,4-oxadiazol-2-yl]-4-quinolinecarboxamide수율 60%

시약·촉매·용매 2

HCID 962Water용매HCID 6228Dimethylformamide용매

실험 절차

Commercially available 2-amino-5-(2-furyl)-1,3,4-oxadiazole (57 mg, 0.38 mmol), HOAt (51 mg, 0.37 mmol), HATU (143 mg, 0.38 mmol), and N,N-diisopropylethylamine (87 μL, 0.50 mmol) were added to a DMF (2 mL) solution of commercially available 2-(4-fluorophenyl)-4-quinolinecarboxylic acid (67 mg, 0.25 mmol), and the mixture was stirred at room temperature for 3 days. To the reaction solution, water was added, and the deposited solid was collected by filtration, and washed with water and then with methanol and methylene chloride in this order. The obtained solid was dried to obtain the title compound (61 mg, 0.15 mmol).

후처리

  1. filtrationthe deposited solid was collected by filtration
  2. washwashed with water
  3. customThe obtained solid was dried

출처 및 근거

ORD 기록
ord-4fb70990186948669737a7c83bc94597
출처 데이터셋
uspto-grants-2013_06
특허 번호
US08466290B2

연결된 노트

불러오는 중…